Rachel McMinn, Chief Executive Officer at Neurogene Inc. (NGNE), bought 95,000 shares at $20.40 ($1.9M) on 2024-11-22, disclosed to the SEC on 2024-11-25.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.40 | 47,500 | $969K | 50.0% |
| 2 | $20.40 | 47,500 | $969K | 50.0% |
| Total | $20.40 avg | 95,000 | $1.9M | 100% |
| Filing → |
| ICPT | SELL | 2017-08-02 | $16K | — | Filing → |
| ICPT | SELL | 2017-07-05 | $31K | — | Filing → |
| ICPT | SELL | 2017-05-03 | $13K | — | Filing → |